ExLibris header image
SFX Logo
Title: Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Source:

Nature Biotechnology [1087-0156] yr:2018


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. RD, S. "Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion." Science 331.6024 (2011): 1565-70. Link to SFX for this item
2. Steen, H. "The ABC's (and XYZ's) of peptide sequencing." Nature reviews. Molecular cell biology 5.9 (2004): 699-711. Link to Full Text for this item Link to SFX for this item
3. Romesberg, Floyd E. "Expansion of the Genetic Alphabet: A Chemist’s Approach to Synthetic Biology." Accounts of chemical research 51.2 (2017): 394-403. Link to Full Text for this item Link to SFX for this item
4. Baker, Sarah Catherine B. M. "Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes." The journal of immunology 199.7 (2017): 2203-2213. Link to SFX for this item
5. Politi, K. "Translational therapeutics in genetically engineered mouse models of cancer." Cold Spring Harbor protocols 2014.2 (2014): 131-43. Link to SFX for this item
6. Vesely, Matthew D. "Natural Innate and Adaptive Immunity to Cancer." Annual review of immunology 29.1 (2010): 235-271. Link to Full Text for this item Link to SFX for this item
7. Dunn, Gavin P P. "Cancer immunoediting: from immunosurveillance to tumor escape." Nature immunology 3.11 (2002): 991-8. Link to Full Text for this item Link to SFX for this item
8. Shankaran, V. "IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity." Nature 410.6832 (2001): 1107-11. Link to Full Text for this item Link to SFX for this item
9. Pardoll, Drew M. "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews. Cancer 12.4 (2012): 252-264. Link to SFX for this item
10. Weinberg, Robert A. "Hallmarks of cancer: the next generation." Cell 144.5 (2011): 646-674. Link to SFX for this item
11. Aebersold, R. "Mass spectrometry-based proteomics." Nature 422.6928 (2003): 198-207. Link to Full Text for this item Link to SFX for this item
12. Mann, M. "Proteomic analysis of post-translational modifications." Nature biotechnology 21.3 (2003): 255-261. Link to Full Text for this item Link to SFX for this item
13. de Hoog, Carmen L L. "Proteomics." Annual review of genomics and human genetics 5.1 (2004): 267-93. Link to Full Text for this item Link to SFX for this item
14. Steen, H. "Proteomics goes quantitative: measuring protein abundance." Trends in biotechnology 20.9: 361-364. Link to SFX for this item
15. Mann, M. "Mass spectrometry-based proteomics turns quantitative." Nature chemical biology 1.5 (2005): 252-62. Link to Full Text for this item Link to SFX for this item
16. Hanahan, D. "The hallmarks of cancer." Cell 100.1 (1999): 57-70. Link to SFX for this item
17. ""Cell-Free Synthetic Biology": Synthetic Biology Meets Cell-Free Protein Synthesis." Methods and Protocols 2.4: 80-. Link to SFX for this item
18. Ceroni, F. "The challenges facing synthetic biology in eukaryotes." Nature Reviews Molecular Cell Biology 19.8 (2018): 1-2. Link to SFX for this item
19. Betz, K. "Structural basis for the selective incorporation of an artificial nucleotide opposite a DNA adduct by a DNA polymerase." Chemical communications 53.94 (2017): 12704-12707. Link to SFX for this item
20. Ayres, Cory M. "Modeling Sequence-Dependent Peptide Fluctuations in Immunologic Recognition." Journal of chemical information and modeling 57.8 (2017): 1990-1998. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced